Multiple Sclerosis: Disease and Treatment Modality Overview

Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity

EXPIRES: 10/09/2015

This course requires completion of survey and a 70% passing quiz grade to receive certificate.

Universal Activity Number: 0048-0000-12-081-H01-P

Course Cost: $10

Article Preview

Description:

It is estimated that about 400,000 people in the United States are living with MS.1 The disease most commonly effects people in Europe, the United States, Canada, Australia, and New Zealand. It appears as though incidence and prevalence increase the farther you get from the Equator. Women tend to be affected 1.5-2.5 times more than men. Peak onset in patients is usually between the ages of 25 and 35, with a sharp increase after adolescence and a shallow decline after the peak age. Genetics play a strong role in multiple sclerosis. It is estimated that one’s risk for MS is 30 times higher if you have a sibling with MS.2 Other environmental factors are thought to contribute include sunlight exposure, infections, vaccines, tobacco, nutrition, and xenobiotics, but no association has been confirmed.2,3

Objectives:

At the completion of this program, the participant will be able to:

1. Identify signs and symptoms associated with multiple sclerosis and describe tests to determine a differential diagnosis of MS

2. Describe each of the categories of MS and be able to classify a patient into a specific clinical course

3. Identify medications used in the treatment of MS, and describe their mechanism of action, administration, side effects, and special considerations

4. Describe methods of symptom management for MS

Instructions: For credit card or checking account payment, pay by clicking the button above. Once payment has been received, email pharmacy technical support to be enrolled into the course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.